Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
Toby Mak
Supply of generic drugs and their interaction with the patent system, like standards essential patents, present one of the international frontiers of patent protection.
Singh & Associates
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
Singh & Associates
In the European Union (EU), 5 mg twice daily is the recommended dose for rheumatoid arthritis and psoriatic arthritis.
Singh & Associates
On January 15, 2019 EMA's Pharmacovigilance Risk Assessment Committee recommended an EU-wide suspension of fenspiride medicines due to the risk of QT prolongation and torsades de pointes ...
Singh & Associates
Last year, an interesting issue with respect to copyrightability of unconventional works was raised before EU's highest legal authority, the Court of Justice, European Union
Khurana and Khurana
In a recent decision, the Divisional bench of Delhi high court has dealt with correct interpretation of Section 107A of the Patents Act, 1970, commonly known as the Bolar provision.
Singh & Associates
Symptoms of immune activation may occur up to 4 years after the start of treatment.
Singh & Associates
Aspirin and Aspirin containing FDCs are widely used formulations, and several such single ingredient, formulations and FDCs are covered under various Pharmacopoeia.
Singh & Associates
Union Health Ministry has proposed to amend Rule 26 of D&C Rules to make it mandatory the import license holder to maintain a reference sample.
Singh & Associates
The Union Health Ministry in a recent update has come up with a plan to amend Rule 65(15)(b) and Rule 65(15) (c) of Drugs and Cosmetics Rules where the word ‘Chemists & Druggists' will be replaced with ...
Singh & Associates
On April 22, 2019, a MOU was signed between the Ministry of AYUSH and CSIR for cooperation in research, education and interdisciplinary sciences that integrate/co-opt traditional systems of medicine and modern science.
Singh & Associates
On March 28, 2019, the central government has amended the conditions for supply of sublingual tablets of Buprenorphine + Naloxone FDC and Buprenorphine alone.
LexOrbis
This is not the first time that these pharma giants have tried hindering the process of generic drug development.
Khurana and Khurana
The Hon'ble High Court of Madras is currently dealing with a very interesting issue "Whether the State Government is an abettor in the alcohol-related crimes or not?"
Nishith Desai Associates
With reports stating that 75% of patients expect to use digital services in the future, the future of healthcare is in the online space.
Khurana and Khurana
There are laws with respect to safeguards and health measures for all citizens in the country.
Nishith Desai Associates
January 01, 2019 marked the first anniversary of the Medical Device Rules 2017 – India's first step in de-linking medical devices regulations from drugs.
Singh & Associates
On March 19, 2019 the U.S. Food and Drug Administration approved Zulresso (brexanolone) intravenous (IV) formulation for the treatment of postpartum depression (PPD) in adult women.
Singh & Associates
On Mar 20, 2019, World Health Organization issued guidelines "WHO Consolidated Guidelines on Drug- Resistant Tuberculosis Treatment" to accelerate the treatment of tuberculosis for proper eradication of the multidrug resistant TB ...
Singh & Associates
Earlier On 27th February, 2019, National Pharmaceuticals Pricing Authority (the ‘NPPA') listed 42 anti-cancer drugs under 30% Trade Margin rationalization.
Latest Video
Most Popular Recent Articles
Khurana and Khurana
The Hon'ble Delhi High Court has recently held that there is no deceptive similarity between the marks "Officer's Choice" and "Fauji" and has rejected Allied Blenders and Distillers Pvt Ltd's trademark infringement suit for its mark ‘Officer's Choice' against the owner of another alcoholic beverage, ‘Fauji'.
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Singh & Associates
On April 22, 2019, a MOU was signed between the Ministry of AYUSH and CSIR for cooperation in research, education and interdisciplinary sciences that integrate/co-opt traditional systems of medicine and modern science.
Khurana and Khurana
Trademarks play a vital role in creating a brand name and goodwill of any business. Not only does it helps in creating a brand value but also, aids in revenue generation.
Khurana and Khurana
There are laws with respect to safeguards and health measures for all citizens in the country.
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Nishith Desai Associates
January 01, 2019 marked the first anniversary of the Medical Device Rules 2017 – India's first step in de-linking medical devices regulations from drugs.
Singh & Associates
On March 19, 2019 the U.S. Food and Drug Administration approved Zulresso (brexanolone) intravenous (IV) formulation for the treatment of postpartum depression (PPD) in adult women.
R. K. Dewan & Co
In our article – ‘Does Your Product Have a Location?1' dated August 13, 2018, we discussed Geographical Indications and their application in India. We bring to you a recent update on the same.
Khurana and Khurana
The Hon'ble High Court of Madras is currently dealing with a very interesting issue "Whether the State Government is an abettor in the alcohol-related crimes or not?"
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter